HomeNews

News

Aspect Results of BGB-16673 Seem Manageable in Early CLL Research

BGB-16673, a first-in-class BTK degrader, is being studied for relapsed or refractory persistent lymphocytic leukemia (CLL) in a part 1 trial, in keeping...

It’s Me, A Most cancers Survivor, I Refuse to Be Ignored

Brian Sluga is now a testicular most cancers survivor after receiving the prognosis when he was 20 years previous. Make amends for Brian's blogs...

A Most cancers Thriver Breaks Down Her Definition of Survivorship

Survivorship can imply one thing totally different to everybody, and it is very important mirror on the totally different definitions of survivorship, particularly...

Prime 5 Updates Sufferers Ought to Know

June introduced main blood most cancers updates, and CURE is sharing the most recent in myelofibrosis remedy and FDA breakthroughs, in addition to...

Making Prostate Most cancers Simpler to Perceive for Newly Recognized Sufferers

Dr. Ravi Munver defined that, for sufferers who're lately recognized with prostate most cancers, it is very important discover remedy possibility with their...

Hot Topics